CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects - González-Lizárraga, Florencia; Ploper, Diego; Ávila, César L.; Socías, Sergio B.; Pereira, Mauricio dos Santos; Machín, Belén; Del Bel, Elaine Aparecida; Michel, Patrick Pierre; Pietrasanta, Lía I.; Raisman-Vozari, Rita; Chehín, Rosana (Scientific Reports, 2020)